108 related articles for article (PubMed ID: 38852755)
1. Aptamer-Drug conjugates for a targeted and synergistic anticancer Response: Exploiting T30923-5-fluoro-2'-deoxyuridine (INT-FdU) derivatives.
Benigno D; Navarro N; Aviñó A; Esposito V; Galeone A; Virgilio A; Fàbrega C; Eritja R
Eur J Pharm Biopharm; 2024 Jun; ():114354. PubMed ID: 38852755
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative Effects of the Aptamer d(GGGT)
Virgilio A; Pecoraro A; Benigno D; Russo A; Russo G; Esposito V; Galeone A
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682635
[TBL] [Abstract][Full Text] [Related]
3. Parallel G-quadruplex Structures Increase Cellular Uptake and Cytotoxicity of 5-Fluoro-2'-deoxyuridine Oligomers in 5-Fluorouracil Resistant Cells.
Clua A; Fàbrega C; García-Chica J; Grijalvo S; Eritja R
Molecules; 2021 Mar; 26(6):. PubMed ID: 33804620
[TBL] [Abstract][Full Text] [Related]
4. Bifunctional G-Quadruplex Aptamer Targeting Nucleolin and Topoisomerase 1: Antiproliferative Activity and Synergistic Effect of Conjugated Drugs.
Jo J; Bae S; Jeon J; Youn H; Lee G; Ban C
Bioconjug Chem; 2023 Jan; 34(1):238-247. PubMed ID: 36516871
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activities of amphiphilic 5-fluoro-2'-deoxyuridylic acid prodrugs.
Ludwig PS; Schwendener RA; Schott H
Eur J Med Chem; 2005 May; 40(5):494-504. PubMed ID: 15893023
[TBL] [Abstract][Full Text] [Related]
6. [Antisense oligonucleotides with antitumor activity].
Otvös L; Sági G
Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2'-deoxyuridine and 2',5-difluoro-2'-deoxyuridine as potential dual action anticancer prodrugs.
Xia Z; Wiebe LI; Miller GG; Knaus EE
Arch Pharm (Weinheim); 1999 Aug; 332(8):286-94. PubMed ID: 10489539
[TBL] [Abstract][Full Text] [Related]
8. ALPPL2 Aptamer-Mediated Targeted Delivery of 5-Fluoro-2'-Deoxyuridine to Pancreatic Cancer.
Dua P; S S; Kim S; Lee DK
Nucleic Acid Ther; 2015 Aug; 25(4):180-7. PubMed ID: 25919296
[TBL] [Abstract][Full Text] [Related]
9. New 3'-O-aromatic acyl-5-fluoro-2'-deoxyuridine derivatives as potential anticancer agents.
Szymańska-Michalak A; Wawrzyniak D; Framski G; Kujda M; Zgoła P; Stawinski J; Barciszewski J; Boryski J; Kraszewski A
Eur J Med Chem; 2016 Jun; 115():41-52. PubMed ID: 26994842
[TBL] [Abstract][Full Text] [Related]
10. Novel anticancer polymeric conjugates of activated nucleoside analogues.
Senanayake TH; Warren G; Vinogradov SV
Bioconjug Chem; 2011 Oct; 22(10):1983-93. PubMed ID: 21863885
[TBL] [Abstract][Full Text] [Related]
11. An aptamer intrinsically comprising 5-fluoro-2'-deoxyuridine for targeted chemotherapy.
Kruspe S; Hahn U
Angew Chem Int Ed Engl; 2014 Sep; 53(39):10541-4. PubMed ID: 25145319
[TBL] [Abstract][Full Text] [Related]
12. Probing the Importance of the G-Quadruplex Grooves for the Activity of the Anti-HIV-Integrase Aptamer T30923.
Esposito V; Esposito F; Pepe A; Gomez Monterrey I; Tramontano E; Mayol L; Virgilio A; Galeone A
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781637
[TBL] [Abstract][Full Text] [Related]
13. Combination of Doxorubicin with Gemcitabine-Incorporated G-Quadruplex Aptamer Showed Synergistic and Selective Anticancer Effect in Breast Cancer Cells.
Joshi M; Choi JS; Park JW; Doh KO
J Microbiol Biotechnol; 2019 Nov; 29(11):1799-1805. PubMed ID: 31546295
[TBL] [Abstract][Full Text] [Related]
14. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
Kim M; Kim DM; Kim KS; Jung W; Kim DE
Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
[TBL] [Abstract][Full Text] [Related]
15. Aptamer-Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells.
Qi J; Zeng Z; Chen Z; Nipper C; Liu X; Wan Q; Chen J; Tung CH; Zu Y
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631384
[TBL] [Abstract][Full Text] [Related]
16. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
[TBL] [Abstract][Full Text] [Related]
17. Conjugate-SELEX: A High-throughput Screening of Thioaptamer-liposomal Nanoparticle Conjugates for Targeted Intracellular Delivery of Anticancer Drugs.
Mu Q; Annapragada A; Srivastava M; Li X; Wu J; Thiviyanathan V; Wang H; Williams A; Gorenstein D; Annapragada A; Vigneswaran N
Mol Ther Nucleic Acids; 2016 Nov; 5(10):e382. PubMed ID: 27802264
[TBL] [Abstract][Full Text] [Related]
18. Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers.
Li Y; Zhao J; Xue Z; Tsang C; Qiao X; Dong L; Li H; Yang Y; Yu B; Gao Y
Front Cell Dev Biol; 2022; 10():1053984. PubMed ID: 36544906
[TBL] [Abstract][Full Text] [Related]
19. G-Quadruplex-Programmed Versatile Nanorobot Combined with Chemotherapy and Gene Therapy for Synergistic Targeted Therapy.
Wang Q; Du Y; Zheng J; Shi L; Li T
Small; 2024 May; ():e2400267. PubMed ID: 38805747
[TBL] [Abstract][Full Text] [Related]
20. Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy.
Wei Z; Zhou Y; Wang R; Wang J; Chen Z
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
